Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gynecologic Oncology

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YGYNO.2007.06.023PMID 17698176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2006

  2006cited by this paper
• Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

  2006cited by this paper
• [u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast].

  2003cited by this paper
• Carcinoma of the ovary

  2003cited by this paper
• „IMO” - Intraoperatives Mapping des Ovarialkarzinoms

  2003cited by this paper
• Characterization of a new family of proteins that interact with the C‐terminal region of the chromatin‐remodeling factor CHD‐31

  2003cited by this paper
• Posttranscriptional regulation of PAI-1 gene expression

  2003cited by this paper
• Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

  2002cited by this paper
• Plasmin/Plasminogen System in Colorectal Cancer

  2002cited by this paper
• Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.

  2001cited by this paper
• Second-line treatment and consolidation therapies in advanced ovarian cancer

  2001cited by this paper
• Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

  2001cited by this paper
• Identification and cDNA Cloning of a Novel RNA-binding Protein That Interacts with the Cyclic Nucleotide-responsive Sequence in the Type-1 Plasminogen Activator Inhibitor mRNA*

  2001cited by this paper
• Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

  2001cited by this paper
• Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI‐1)

  2001cited by this paper
• Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer.

  2000cited by this paper
• Urokinase and Plasminogen Activator-Inhibitor (PAI-1) Status in Primary Ovarian Carcinomas and Ovarian Metastases Compared to Benign Ovarian Tumors as A Function of Histopathological Parameters

  1999cited by this paper
• Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues.

  1999cited by this paper
• Plasminogen activator inhibitor‐1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

  1998cited by this paper
• Operative Results after Primary and Secondary Debulking‐Operations in Advanced Ovarian Cancer (AOC)

  1998cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

  1997cited by this paper
• Expression of urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in benign, borderline, malignant primary and metastatic ovarian tumors

  1996cited by this paper
• Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.

  1995cited by this paper
• Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer.

  1994cited by this paper
• Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.

  1994cited by this paper
• Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.

  1994cited by this paper
• The plasminogen‐activation system in ovarian tumors

  1993cited by this paper
• Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

  1992cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper
• © 1999 Cancer Research Campaign Article no. bjoc.1998.0278 Prognostic significance of urokinase (uPA) and its

  year unknowncited by this paper

• The 1H, 15N and 13C backbone resonance assignments of the N-terminal (1-149) domain of Serpine mRNA Binding Protein 1 (SERBP1)

  2025cites this paper
• SERBP1: A Multifunctional RNA-Binding Protein Linking Gene Expression, Cellular Metabolism, and Diseases

  2025cites this paper
• Regional Proteomic Characterization of Uterine Leiomyomas: Implications for Molecular Pathways and Tumor Biology

  2025cites this paper
• KSHV vIL-6 promotes SIRT3-induced deacetylation of SERBP1 to inhibit ferroptosis and enhance cellular transformation by inducing lipoyltransferase 2 mRNA degradation

  2024cites this paper
• Mechanism of Action of the Traditional Chinese Medicine Formula Weichang'an in the Treatment of Gastric Cancer Based on TMT Proteomics Analysis

  2024cites this paper
• Downregulation of GhALKBH10B improves drought tolerance through increasing the stability of photosynthesis related- and ABA signaling pathway genes in cotton

  2024cites this paper
• Ribosomal dormancy at the nexus of ribosome homeostasis and protein synthesis

  2024cites this paper
• Mass spectrometry imaging in gynecological cancers: the best is yet to come

  2022cites this paper
• RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment

  2022cites this paper
• SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells

  2022cites this paper
• Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

  2021cites this paper
• miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer

  2021cites this paper
• New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling.

  2021cites this paper
• Structural Characterization of the RNA-Binding Protein SERBP1 Reveals Intrinsic Disorder and Atypical RNA Binding Modes

  2021influential citation
• The 1H, 15N and 13C resonance assignments of the C-terminal domain of Serpine mRNA binding protein 1 (SERBP1)

  2021cites this paper
• CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression.

  2021cites this paper
• Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma

  2020cites this paper
• OTT_A_250355 6539..6551

  2020cites this paper
• Intracellular hyaluronic acid-binding protein 4 (HABP4): a candidate tumor suppressor in colorectal cancer

  2020cites this paper
• The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation

  2020cites this paper
• lncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis

  2020cites this paper
• Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions

  2019cites this paper
• The mRNA‐binding protein Serbp1 as an auxiliary protein associated with mammalian cytoplasmic ribosomes

  2018cites this paper
• Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma

  2018cites this paper
• Investigation of RNA binding proteins regulated by mTOR

  2017cites this paper
• iTRAQ-based quantitative proteomic analysis of midgut in silkworm infected with Bombyx mori cytoplasmic polyhedrosis virus.

  2017cites this paper
• Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network

  2017cites this paper
• Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer

  2017cites this paper
• MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1

  2017cites this paper
• Diverse and pervasive subcellular distributions for both coding and long noncoding RNAs

  2016cites this paper
• Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1

  2016cites this paper
• Expression of Progesterone Receptor Membrane Component 1 (PGRMC1), Progestin and AdipoQ Receptor 7 (PAQPR7), and Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) in Glioma Spheroids In Vitro

  2016cites this paper
• Physiology, production and action of progesterone

  2015cites this paper
• SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase

  2015cites this paper
• SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.

  2015cites this paper
• Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

  2015cites this paper
• Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression

  2014cites this paper
• Ki-1/57 and CGI-55 ectopic expression impact cellular pathways involved in proliferation and stress response regulation.

  2014cites this paper
• Reverse Engineering of Modified Genes by Bayesian Network Analysis Defines Molecular Determinants Critical to the Development of Glioblastoma

  2013cites this paper
• Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution

  2012influential citation
• Novel differential transcript expression identified by LongSAGE in the mouse endometrium during the implantation window

  2012cites this paper
• Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

  2012influential citation
• Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid

  2012cites this paper
• Roles for Chd7 in zebrafish development with implications for human disease

  2012cites this paper
• Differential Expression of PAI-RBP1, C1orf142, and COTL1 in Non–Small Cell Lung Cancer Cell Lines With Different Tumor Metastatic Potential

  2012influential citation
• Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.

  2010cites this paper
• Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors

  2010cites this paper
• Molecular cloning and functional studies of tenascin-C isoforms containing the fibronectin-type III repeat additional domain 1 (AD1)

  2009cites this paper
• n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon.

  2009cites this paper
• Proteomic characterisation of pancreatic islet β-cells stimulated with pancreatic carcinoma cell conditioned medium

  2009cites this paper
• Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells

  2008cites this paper
• Non-genomic progesterone actions in female reproduction.

  2008cites this paper
• Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue

  2008cites this paper